Mirtazapine Tablet, Film Coated
Product Images NDC 70518-1838

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-1838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Mirtazapine is a prescription-only medication with NDC number 70518-1838-00. The medication is manufactured by Aurcbindo Pharma, located in Dayton, NJ 08810, and the Repackaging is done by RemedyRepack Inc in Indiana, PA 15701. The LOT and expiry date are not available. The package insert should be checked before use, and the medication should be stored at temperatures between 20-26°C (63-77°F) with excursions permissible to 15-30°C (59-86°F) as per USP regulations. Keep the medication out of children's reach.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.